Madrigal Pharmaceuticals, Inc. (MDGL) stock
MDGLNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 5/304% above fair value
$398.08−23.91 (-5.67%)
Close on Nov 18, 2026Market cap $9.20BP/E –Yield –
Madrigal Pharmaceuticals revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
Madrigal Pharmaceuticals's revenue for the twelve months ending Jun 30, 2026 was $1.28B, up 149.0% year over year. For fiscal 2025 it was $958.40M, up 432.1% from the year before. The highest annual figure on record is $958.40M in fiscal 2025.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $958.40M | +432.1% |
| FY2024 | Dec 31, 2024 | $180.13M | – |
| FY2023 | Dec 31, 2023 | $0 | – |
| FY2022 | Dec 31, 2022 | $0 | – |
| FY2021 | Dec 31, 2021 | $0 | – |
| FY2020 | Dec 31, 2020 | $0 | – |
| FY2019 | Dec 31, 2019 | $0 | – |
| FY2018 | Dec 31, 2018 | $0 | – |
| FY2017 | Dec 31, 2017 | $0 | -100.0% |
| FY2012 | Dec 31, 2012 | $147.00K | – |
Quarterly revenue
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $364.25M | +71.2% |
| Q1 FY2026 | Mar 31, 2026 | $311.34M | +126.8% |
| Q4 FY2025 | Dec 31, 2025 | $321.08M | +210.8% |
| Q3 FY2025 | Sep 30, 2025 | $287.27M | +362.0% |
| Q2 FY2025 | Jun 30, 2025 | $212.80M | +1353.8% |
| Q1 FY2025 | Mar 31, 2025 | $137.25M | – |
| Q4 FY2024 | Dec 31, 2024 | $103.32M | – |
| Q3 FY2024 | Sep 30, 2024 | $62.18M | – |
| Q2 FY2024 | Jun 30, 2024 | $14.64M | – |
| Q1 FY2024 | Mar 31, 2024 | $0 | – |
| Q4 FY2023 | Dec 31, 2023 | $0 | – |
| Q3 FY2023 | Sep 30, 2023 | $0 | – |
| Q2 FY2023 | Jun 30, 2023 | $0 | – |
| Q1 FY2023 | Mar 31, 2023 | $0 | – |
| Q4 FY2022 | Dec 31, 2022 | $0 | – |
| Q3 FY2022 | Sep 30, 2022 | $0 | – |
| Q2 FY2022 | Jun 30, 2022 | $0 | – |
| Q1 FY2022 | Mar 31, 2022 | $0 | – |
| Q4 FY2021 | Dec 31, 2021 | $0 | – |
| Q3 FY2021 | Sep 30, 2021 | $0 | – |
| Q2 FY2021 | Jun 30, 2021 | $0 | – |
| Q1 FY2021 | Mar 31, 2021 | $0 | – |
| Q4 FY2020 | Dec 31, 2020 | $0 | – |
| Q3 FY2020 | Sep 30, 2020 | $0 | – |
| Q2 FY2020 | Jun 30, 2020 | $0 | – |
| Q1 FY2020 | Mar 31, 2020 | $0 | – |
| Q4 FY2019 | Dec 31, 2019 | $0 | – |
| Q3 FY2019 | Sep 30, 2019 | $0 | – |
| Q2 FY2019 | Jun 30, 2019 | $0 | – |
| Q1 FY2019 | Mar 31, 2019 | $0 | – |
| Q4 FY2018 | Dec 31, 2018 | $0 | – |
| Q3 FY2018 | Sep 30, 2018 | $0 | – |
| Q2 FY2018 | Jun 30, 2018 | $0 | – |
| Q1 FY2018 | Mar 31, 2018 | $0 | – |
See a number that looks wrong?